Literature DB >> 16317633

[Medical and behavioural aspects of Angelman syndrome].

J Artigas-Pallarés1, C Brun-Gasca, E Gabau-Vila, M Guitart-Feliubadaló, C Camprubí-Sánchez.   

Abstract

INTRODUCTION: Angelman syndrome (AS) is a genetically-based disorder that is characterised by a physical and behavioural phenotype. Additionally, it presents a number of different systemic conditions that must also be taken into account. To evaluate the symptomatic spectrum of AS, we sought the aid of families linked to AS associations by sending them a questionnaire designed to investigate the clinical characteristics of AS. PATIENTS AND METHODS: The families were sent a questionnaire aimed at determining the medical and behavioural characteristics of AS. Results from 68 patients were analysed.
RESULTS: The mean age at diagnosis was 4.8 years. The first symptoms that called parents' attention were feeding problems, followed by gastroesophageal reflux and hypotonia. The mean age at which patients were capable of maintaining a sitting posture was 18 months, while autonomous walking was not achieved until 43 months. Epilepsy, which was present in 91% of cases, began with febrile seizures in 55% of patients. In this study we found that a high percentage of patients with AS have a high resistance to pain (67%), a very common symptom in Prader-Willi syndrome, but little known in AS.
CONCLUSIONS: This study offers a wide array of information about the clinical spectrum of AS obtained from an extensive populational sample. Some highly prevalent clinical aspects, such as the relative insensitivity to pain, have not been reported in previous publications as a symptom that is typical of AS.

Entities:  

Mesh:

Year:  2005        PMID: 16317633

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  4 in total

1.  Autism Spectrum Disorder, Intellectual Disability, and Delayed Walking.

Authors:  Somer L Bishop; Audrey Thurm; Cristan Farmer; Catherine Lord
Journal:  Pediatrics       Date:  2016-02-03       Impact factor: 7.124

2.  Enhanced Nociception in Angelman Syndrome Model Mice.

Authors:  Eric S McCoy; Bonnie Taylor-Blake; Megumi Aita; Jeremy M Simon; Benjamin D Philpot; Mark J Zylka
Journal:  J Neurosci       Date:  2017-09-20       Impact factor: 6.167

Review 3.  Pathophysiology of Nociception and Rare Genetic Disorders with Increased Pain Threshold or Pain Insensitivity.

Authors:  Marco Cascella; Maria Rosaria Muzio; Federica Monaco; Davide Nocerino; Alessandro Ottaiano; Francesco Perri; Massimo Antonio Innamorato
Journal:  Pathophysiology       Date:  2022-08-02

4.  Behavior and neuropsychiatric manifestations in Angelman syndrome.

Authors:  Karine Pelc; Guy Cheron; Bernard Dan
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.